Dual Time Point FDG PET/MRI Scan in Improving the Imaging Cancer Patients With Brain Metastases

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 3, 2018

Primary Completion Date

April 26, 2024

Study Completion Date

April 26, 2024

Conditions

Metastatic Malignant Neoplasm in the BrainMetastatic Malignant Solid Neoplasm

Interventions

RADIATION

Fludeoxyglucose F-18

Given IV

PROCEDURE

Magnetic Resonance Imaging

Undergo PET/MRI

PROCEDURE

Positron Emission Tomography

Undergo PET/MRI

Trial Locations (1)

M D Anderson Cancer Center, Houston

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER

NCT05054998 - Dual Time Point FDG PET/MRI Scan in Improving the Imaging Cancer Patients With Brain Metastases | Biotech Hunter | Biotech Hunter